A pancreatic cancer drug discovered in professors Paul Bingham and Zuzana Zachar’s lab in the Department of Biochemistry and Cell Biology at Stony Brook University has now entered Phase III, or multi-center testing stage.

Assistant professor David Q. Matus studies the process of cell invasion and its misregulation in diseases such as cancer metastasis.